# Prelude Therapeutics Inc: Form 8-K, filed Jul 19, 2021

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: 8-K
- Filed: 2021-07-19
- Accepted by EDGAR: Jul 19, 2021, 16:53 ET
- Period: 2021-07-15
- Accession: 0001193125-21-218690
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000119312521218690/d172272d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000119312521218690/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000119312521218690/d172272d8k.htm

Filed Jul 19, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-218690. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
